Sean Maduck Corcept Therapeutics Inc (CORT) insider trading activity

Sean Maduck is of CORCEPT THERAPEUTICS INC. Currently has a direct ownership of 17,705 shares of CORT, which is worth approximately $1.26 Million. The most recent transaction as insider was on Jun 02, 2025, when has been sold 20,000 shares (Common Stock) at a price of $79.36 per share, resulting in proceeds of $1,587,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.7K

79.32% 3M change

79.02% 12M change

Total Value Held $1.26 Million

Sean Maduck Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 02 2025	SELL Open market or private sale	$1,587,200 $79.36 p/Share	20,000 Reduced 53.04%	17,705 Common Stock
Jun 02 2025	BUY Grant, award, or other acquisition	$557,030 $25.58 p/Share	21,776 Added 36.61%	37,705 Common Stock
May 29 2025	SELL Bona fide gift	-	10,000 Reduced 38.57%	15,929 Common Stock
May 29 2025	BUY Exercise of conversion of derivative security	$38,800 $3.88 p/Share	10,000 Added 27.83%	25,929 Common Stock
May 02 2025	SELL Open market or private sale	$1,927,820 $72.6 p/Share	26,554 Reduced 23.67%	85,622 Common Stock
May 02 2025	BUY Exercise of conversion of derivative security	$134,097 $5.05 p/Share	26,554 Added 19.14%	112,176 Common Stock
May 01 2025	SELL Open market or private sale	$924,860 $71.94 p/Share	12,856 Reduced 13.05%	85,622 Common Stock
May 01 2025	BUY Exercise of conversion of derivative security	$64,922 $5.05 p/Share	12,856 Added 11.55%	98,478 Common Stock
Apr 01 2025	SELL Open market or private sale	$67,584 $114.55 p/Share	590 Reduced 0.68%	85,622 Common Stock
Apr 01 2025	BUY Exercise of conversion of derivative security	$2,979 $5.05 p/Share	590 Added 0.68%	86,212 Common Stock
Mar 31 2025	SELL Open market or private sale	$10,128,000 $101.28 p/Share	100,000 Reduced 53.87%	85,622 Common Stock
Mar 31 2025	BUY Exercise of conversion of derivative security	$827,000 $8.27 p/Share	100,000 Added 35.01%	185,622 Common Stock
Mar 24 2025	SELL Open market or private sale	$102,804 $60.58 p/Share	1,697 Reduced 1.94%	85,622 Common Stock
Mar 24 2025	BUY Exercise of conversion of derivative security	$8,569 $5.05 p/Share	1,697 Added 1.91%	87,319 Common Stock
Mar 03 2025	SELL Open market or private sale	$1,110,809 $60.69 p/Share	18,303 Reduced 17.61%	85,622 Common Stock
Mar 03 2025	SELL Payment of exercise price or tax liability	$13,812 $60.58 p/Share	228 Reduced 0.27%	85,090 Common Stock
Mar 03 2025	BUY Exercise of conversion of derivative security	$92,430 $5.05 p/Share	18,303 Added 14.97%	103,925 Common Stock
Mar 03 2025	BUY Grant, award, or other acquisition	$15,715 $29.54 p/Share	532 Added 0.62%	85,622 Common Stock
Feb 03 2025	SELL Open market or private sale	$1,338,400 $66.92 p/Share	20,000 Reduced 18.99%	85,318 Common Stock
Feb 03 2025	BUY Exercise of conversion of derivative security	$89,400 $4.47 p/Share	20,000 Added 15.96%	105,318 Common Stock
Jan 02 2025	SELL Open market or private sale	$1,007,800 $50.39 p/Share	20,000 Reduced 18.99%	85,318 Common Stock
Jan 02 2025	BUY Exercise of conversion of derivative security	$77,600 $3.88 p/Share	20,000 Added 15.96%	105,318 Common Stock
Dec 02 2024	SELL Payment of exercise price or tax liability	$17,015 $57.68 p/Share	295 Reduced 0.35%	84,788 Common Stock
Dec 02 2024	BUY Grant, award, or other acquisition	$15,693 $29.61 p/Share	530 Added 0.62%	85,318 Common Stock
Sep 03 2024	SELL Payment of exercise price or tax liability	$8,189 $35.3 p/Share	232 Reduced 0.27%	84,167 Common Stock

Sean Maduck

Menlo Park, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CORT shares.

Notify only if

Value

Insider Trading

Get notified when an Corcept Therapeutics Inc insider buys or sells CORT shares.

Notify only if

Operation

Value

Type

News

Receive news related to CORCEPT THERAPEUTICS INC

Track Activities on CORT

Account